Audentes Therapeutics, Inc. - FORM S-1/A - EX-23.1 - CONSENT OF KPMG LLP

file	filename
EX-10.7 - EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN THE REGISTRANT AND JOHN GRAY - Audentes Therapeutics, Inc.	d892618dex107.htm
S-1/A - AMENDMENT NO. 3 TO FORM S-1 - Audentes Therapeutics, Inc.	d892618ds1a.htm
EX-10.6 - EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN THE REGISTRANT AND SUYASH PRASAD - Audentes Therapeutics, Inc.	d892618dex106.htm
EX-10.5 - EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN THE REGISTRANT AND MATTHEW PATTERSON - Audentes Therapeutics, Inc.	d892618dex105.htm
EX-10.4 - 2016 EMPLOYEE STOCK PURCHASE PLAN - Audentes Therapeutics, Inc.	d892618dex104.htm
EX-10.3 - 2016 EQUITY INCENTIVE PLAN - Audentes Therapeutics, Inc.	d892618dex103.htm
EX-10.1 - FORM OF INDEMNITY AGREEMENT - Audentes Therapeutics, Inc.	d892618dex101.htm
EX-5.1 - OPINION OF FENWICK & WEST LLP - Audentes Therapeutics, Inc.	d892618dex51.htm
EX-3.4 - FORM OF RESTATED BYLAWS - Audentes Therapeutics, Inc.	d892618dex34.htm
EX-3.2 - FORM OF RESTATED CERTIFICATE OF INCORPORATION - Audentes Therapeutics, Inc.	d892618dex32.htm
EX-3.1 - RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED - Audentes Therapeutics, Inc.	d892618dex31.htm
EX-1.1 - FORM OF UNDERWRITING AGREEMENT - Audentes Therapeutics, Inc.	d892618dex11.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

Audentes Therapeutics, Inc.:

We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.

/s/ KPMG LLP

San Francisco, California

July 7, 2016

Audentes Therapeutics, Inc. - FORM S-1/A - EX-23.1 - CONSENT OF KPMG LLP - July 11, 2016